Patients who regularly miss doses benefit more from injectable HIV medication than oral medication, according to a study.

Published Date: 15 May 2024

Antiretroviral therapy, which is a lifelong HIV treatment regimen, is started when a person is diagnosed in order to control the virus. However, many people find it difficult to take medication on a daily basis.

Read Full News

Latest News

Is AD Transmissible? The Evidence for ‘Iatrogenic’ Disease

Evidence for medically transmitted amyloid pathology is mounting, but whether Alzheimer’s disease itself can be transmitted — and what it means for patients — remains unsettled.

Dr Reddy's Signs India Distribution Deal for Takeda's Qdenga Dengue Vaccine

Dr Reddy's Laboratories said on Friday it had ⁠signed an agreement with Japanese drugmaker Takeda Pharmaceutical to ⁠promote and distribute the Qdenga dengue vaccine in...

Screwworm Infests US Horse Before Port Reopens to Mexican Livestock

The U.S. confirmed a case of New World screwworm in a horse in New Mexico on Thursday, as the ⁠federal government prepared to resume imports of Mexican livestock into the...

CDC Delay Holds Up Children's COVID Vaccine Orders, WSJ Reports

U.S. states are facing delays in obtaining COVID-19 vaccines for children through a federal immunization program, the Wall Street Journal reported ⁠Wednesday, citing people...

Exclusive-Pennsylvania Asks for CDC Measles Help Amid Kennedy Dispute

The Pennsylvania health department has requested emergency support from the US CDC as it grapples with one of the country's largest and most deadly measles outbreaks, though...

Older Adults Living With HIV: A New Focus on Healthy Aging

The growing number of older adults with HIV brings multimorbidity, functional decline, stigma, and end-of-life planning to long-term care.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Todays Updates

Trappsol Cyclo Misses Primary End Point in Phase 3 Trial for Niemann-Pick Disease Type C Isabella Ciccone, MPH

Findings from the phase 3 TransportNPC study showed that Trappsol Cyclo missed the primary end point in Niemann-Pick type C, but subgroup and survival data support planned 2026 NDA.

NeurologyLive® Friday 5 — October 2, 2026 Isabella Ciccone, MPH

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 2, 2026.

Latest News

Evidence for medically transmitted amyloid pathology is mounting, but whether Alzheimer’s disease itself can be transmitted — and what it means for patients — remains unsettled.

Dr Reddy's Laboratories said on Friday it had ⁠signed an agreement with Japanese drugmaker Takeda Pharmaceutical to ⁠promote and distribute the Qdenga dengue vaccine in...

The U.S. confirmed a case of New World screwworm in a horse in New Mexico on Thursday, as the ⁠federal government prepared to resume imports of Mexican livestock into the...

U.S. states are facing delays in obtaining COVID-19 vaccines for children through a federal immunization program, the Wall Street Journal reported ⁠Wednesday, citing people...

The Pennsylvania health department has requested emergency support from the US CDC as it grapples with one of the country's largest and most deadly measles outbreaks, though...

The growing number of older adults with HIV brings multimorbidity, functional decline, stigma, and end-of-life planning to long-term care.

News All Time

Daily Probiotic Fails to Prevent Infections in Infants

Daily use of an oral probiotic from 6 to 24 months of age may not reduce the occurrence of ear or respiratory tract infections and antibiotic use in healthy infants.

Once-Monthly PrEP Drug Could Be Manufactured for $3 a Year

The current agreement manufacturer Merck has signed for global access to its once-monthly alimatravir would exclude countries with more than 230,000 new HIV acquisitions a year.

Testing for Duffy-Null Neutrophil Count Before Consult

By adding Duffy antigen testing to routine blood bank screens, VA identified 79 DANC patients, sparing many unnecessary bone marrow biopsies.

WHO Says Staff Shortage, Funding Challenges Hamper Congo Ebola Response

Shortages of trained staff, operational partners and funding are causing a bottleneck in efforts to expand the Ebola response in the Democratic Republic of Congo as the...

Lessons From Recent Viral Outbreaks

Despite advances in diagnostics and trial speeds, gaps in clinical care capacity, targeted therapies, and public communication threaten global preparedness for the next pandemic.

Cyclosporiasis Cases in Michigan Climb to Over 14,700, State Health Officials Say

Michigan health officials reported 14,718 cases linked to an outbreak of cyclosporiasis on Thursday, an increase ⁠of 208 cases since its last update a week...

Salmonella Outbreak Linked to Pumpkin Seeds Infects 81 in France

An outbreak of salmonella related to ⁠a batch of pumpkin seeds infected 81 people, ⁠hospitalising six, in several French regions between ⁠May and August, ‌the Health and...

As Schools Re-open, Congo Drops Remote Learning Plan in Ebola Red Zone

Schools reopened this week in areas of Democratic Republic of Congo hardest hit by Ebola, after authorities decided the risk of transmission ⁠was outweighed by the risk of...

WHO's Tedros Says Ebola Response Must Be Scaled Up to Tackle Congo Outbreak

The head of the World Health Organization on Wednesday said the Ebola response needs to be scaled up to tackle the outbreak in the Democratic Republic ⁠of Congo, with...

Gepotidacin as Effective as Standard Therapy for Gonorrhea

Nucleic acid amplification test-confirmed success rates for urogenital gonorrhea are high and similar to those of oral gepotidacin and ceftriaxone plus azithromycin, a phase 3 trial shows.

Health Officials Turn to Mobile-phone Data to Track Ebola Spread in Congo

Health officials battling the Ebola outbreak in eastern Democratic Republic of Congo are using anonymised mobile-phone data to map population movements and identify areas...

GSK to Advance MRNA Flu Vaccine to Late-stage Trial

(Corrects paragraph 4 to clarify that GSK plans to start more than 20, ⁠not 25, late-stage trials in 2026)

UK Pledges Additional £50 Million to Help Contain Ebola Outbreak in Congo

Britain said on Tuesday it would provide more than £50 ⁠million ($67.56 million) in new funding to support efforts to contain an ⁠Ebola outbreak in the Democratic Republic...

Congo's Ebola Outbreak Kills More Than 3,000, Government Figures Show

The number of deaths in Democratic Republic of Congo's Ebola outbreak has surpassed 3,000, government ⁠data showed on Wednesday, as the country's worst-ever epidemic...

USDA Cyclospora Research Projects Shelved Amid Funding Cuts and Relocations, Politico Reports

The Trump administration is shuttering two of the three U.S. Department of Agriculture research projects studying cyclospora, ⁠a foodborne parasite that has sickened...

Measles Cases in Pennsylvania Rise to 460 Amid Ongoing Outbreak

Pennsylvania's health department said on Friday the confirmed number of cases linked to a measles ⁠outbreak has reached 460 this year, an increase of 36 over its update two...

Recommended News For You

For relapsed or resistant DLBCL, odronextamab produced positive results.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Trump Issues Gag Order for CDC, FDA; Stalled Hearing for RFK Jr.; Sex After Cancer

Utilizing cerium/lanthanum-134 to improve cancer detection and treatment.

No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy.

Lesser-known lobular breast cancer on the rise in U.S. women

Recommended Articles For You

Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology 

The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy 

What Is Degos Disease? A Comprehensive Overview Of Symptoms, Diagnosis, and Treatment 

The Silent Killer: Uncovering the Causes and Treatments of Hemorrhagic Gastritis 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Datopotamab Deruxtecan Earns New Breast Cancer Indication

2.

Both DNA damage repair deficiency and non-Hodgkin lymphoma are the focus of LP-284.

3.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

4.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

5.

CAR T-Cell Therapy in Functional High-Risk Multiple Myeloma

1.

Engineered Red Blood Cell Therapeutics: Emerging Applications

2.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

3.

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined

4.

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

5.

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

1.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

2.

Chemotherapy: What to Expect

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

From Guidelines to Practice: Hematology

5.

Early Warning Signs of Cancer

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot